Table 2 Patient baseline characteristics (n = 112)
Characteristics | Value |
|---|---|
Age, years (Mean ± SD) | 58.4 ± 12.5 (range, 26–88) |
≥ 60, n (%) | 53 (47.3) |
< 60, n (%) | 59 (52.7) |
Gender, n (%) | |
Male | 72 (64.3) |
Female | 40 (35.7) |
TNM-Stage#, n (%) | |
II | 37 (33.0) |
III | 75 (67.0) |
T-stage, n (%) | |
T2 | 14 (12.5) |
T3 | 90 (80.4) |
T4 | 8 (7.1) |
N-stage, n (%) | |
N0 | 37 (33.0) |
N1 | 61 (54.5) |
N2 | 14 (12.5) |
MRF, n (%) | |
negative | 95 (84.8) |
positive | 17 (15.2) |
EMVI, n (%) | |
negative | 83 (74.1) |
positive | 29 (25.9) |
Treatment strategy, n (%) | |
Surgery only | 11 (9.8) |
NAT + Surgery | 8 (7.2) |
Surgery + AT | 66 (58.9) |
NAT + Surgery + AT | 27 (24.1) |
Progression and Survival, n (%) | |
Local recurrence | 2 (1.8) |
SODM | 15 (13.4) |
MODM | 5 (4.5) |
LRDM | 3 (2.7) |
Death | 18 (16.1) |
Differentiation, n (%) | |
Well | 11 (9.8) |
Moderate | 54 (48.2) |
Poor | 12 (10.7) |
Unavailable | 35 (31.3) |